Related Experiment Video
Updated: Mar 17, 2026

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
Published on: September 22, 2023
[Proton pump inhibitors: not as safe as they seem]
N van Herwaarden1, J M Bos, B Veldman
1Canisius-Wilhelmina Ziekenhuis, Nijmegen.
Proton pump inhibitors (PPIs) are widely used but can cause serious side effects like infections and nutrient deficiencies. Prescribe PPIs judiciously and monitor patients for potential adverse events.
Area of Science:
- Gastroenterology
- Pharmacology
- Internal Medicine
Background:
- Proton pump inhibitors (PPIs) are frequently prescribed globally.
- Widespread use raises concerns about inappropriate prescriptions and potential adverse effects.
- Growing evidence links PPIs to various serious health issues.
Purpose of the Study:
- To review the incidence and prevalence of significant side effects associated with PPI use.
- To highlight the importance of appropriate PPI indication and ongoing patient monitoring.
- To inform clinicians about potential PPI-related adverse events.
Main Methods:
- Literature review and synthesis of existing data on PPI side effects.
- Analysis of reported cases and epidemiological studies.
- Overview of specific adverse events including infections, metabolic disturbances, and bone health.
Main Results:
- PPIs are associated with increased risks of gastroenteritis and respiratory tract infections.
- Long-term use may lead to hypomagnesemia, renal dysfunction, and deficiencies in vitamin B12 and iron.
- Potential links to dementia, osteoporosis, and fractures are increasingly recognized.
Conclusions:
- Judicious prescribing of PPIs, based on clear indications, is crucial.
- Regular reassessment of the need for continued PPI therapy is recommended for chronic users.
- Clinicians should consider PPIs as a potential cause when adverse effects manifest.
More Related Videos
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

